RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker

RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker

Immune checkpoint inhibitors have been approved for the treatment of advanced hepatocellular carcinoma (HCC). However, immunotherapy requires the identification of suitable biomarkers to guide treatment. The gene for rhomboid 5 homolog 2 (IRHom2), which encodes the rhombus protease iRhom2, activates...

Full description

Bibliographic Details
Main Authors: Hanjuan Gong, Hailun Xie, Zhimin Huangfu, Shuxian Zhang, Yi Tang, Ming Xiao, Ming Li, Yalan Wang
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:FEBS Open Bio
Subjects:
bioinformatics analysis
hepatocellular carcinoma
immune infiltration
prognostic biomarker
RHBDF2
Online Access:https://doi.org/10.1002/2211-5463.13598

Internet

https://doi.org/10.1002/2211-5463.13598

Similar Items